JBS N.V. Financials
This page shows JBS N.V. (JBS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
JBS’s profit recovery has turned into a cash-conversion challenge, as growth absorbs working capital and heavier reinvestment.
After returning to profitability, operating cash flow still slipped to$2.9B while net income reached$2.2B , showing the rebound was less cash-rich than the income statement implies. That gap lines up with a larger inventory build and heavier reinvestment, as inventory rose to$6.1B and free cash flow margin compressed to1.0% .
The balance sheet is more liability-funded than the debt ratio alone suggests: reported debt-to-equity was just 0.1x, but total liabilities were about 3.7x equity, pointing to meaningful reliance on non-debt obligations as part of day-to-day financing. Near-term liquidity still looks serviceable because current assets covered current liabilities by 1.6x, so FY2025’s weaker cash conversion looks more like cash tied up inside operations than a short-term funding crunch.
Capital allocation tightened in FY2025: capital spending rose to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of JBS N.V.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
JBS N.V.'s revenue grew 11.7% year-over-year to $86.2B, a solid pace of expansion. This earns a growth score of 62/100.
JBS N.V. carries a low D/E ratio of 0.15, meaning only $0.15 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 78/100, indicating a strong balance sheet with room for future borrowing.
JBS N.V.'s current ratio of 1.60 indicates adequate short-term liquidity, earning a score of 44/100. The company can meet its near-term obligations, though with limited headroom.
While JBS N.V. generated $2.9B in operating cash flow, capex of $2.1B consumed most of it, leaving $832.7M in free cash flow. This results in a low score of 35/100, reflecting heavy capital investment rather than weak cash generation.
JBS N.V. passes 7 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, JBS N.V. generates $1.31 in operating cash flow ($2.9B OCF vs $2.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
JBS N.V. generated $86.2B in revenue in fiscal year 2025. This represents an increase of 11.7% from the prior year.
JBS N.V. reported $2.2B in net income in fiscal year 2025. This represents an increase of 13.3% from the prior year.
Cash & Balance Sheet
JBS N.V. generated $832.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 69.7% from the prior year.
JBS N.V. held $4.6B in cash against $1.4B in long-term debt as of fiscal year 2025.
Margins & Returns
JBS N.V.'s net profit margin was 2.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.0 percentage points from the prior year.
JBS N.V.'s ROE was 23.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.8 percentage points from the prior year.
Capital Allocation
JBS N.V. invested $2.1B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 41.8% from the prior year.
JBS Income Statement
| Metric | Q4'25 | Q3'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|
| Revenue | N/A | $22.6B | N/A | $19.9B |
| Cost of Revenue | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | -$408.1M | N/A | -$361.1M |
| Income Tax | N/A | $171.2M | N/A | $440.5M |
| Net Income | N/A | $644.1M | N/A | $756.6M |
| EPS (Diluted) | N/A | N/A | N/A | N/A |
JBS Balance Sheet
| Metric | Q4'25 | Q3'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|
| Total Assets | $45.2B+2.2% | $44.2B+8.6% | $40.7B | N/A |
| Current Assets | $18.4B+4.3% | $17.7B+3.2% | $17.1B | N/A |
| Cash & Equivalents | $4.6B+28.3% | $3.6B-36.6% | $5.6B+10.7% | $5.1B |
| Inventory | $6.1B-7.0% | $6.6B+31.0% | $5.0B | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A |
| Goodwill | $5.9B-0.8% | $5.9B+8.9% | $5.4B | N/A |
| Total Liabilities | $35.6B+2.8% | $34.7B+6.5% | $32.6B | N/A |
| Current Liabilities | $11.5B+4.6% | $11.0B-5.4% | $11.7B | N/A |
| Long-Term Debt | $1.4B-2.0% | $1.4B+3.1% | $1.4B | N/A |
| Total Equity | $9.5B+0.1% | $9.5B+16.9% | $8.1B-14.2% | $9.5B |
| Retained Earnings | N/A | $1.7B | N/A | N/A |
JBS Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|
| Operating Cash Flow | $1.9B | N/A | $1.5B | N/A |
| Capital Expenditures | $838.3M | N/A | $529.7M | N/A |
| Free Cash Flow | $1.1B | N/A | $1.0B | N/A |
| Investing Cash Flow | -$853.5M | N/A | -$492.1M | N/A |
| Financing Cash Flow | -$38.0M | N/A | -$321.0M | N/A |
| Dividends Paid | $0 | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A |
JBS Financial Ratios
| Metric | Q4'25 | Q3'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A |
| Net Margin | N/A | 2.9% | N/A | 3.8% |
| Return on Equity | N/A | 6.8% | N/A | 8.0% |
| Return on Assets | N/A | 1.5% | N/A | N/A |
| Current Ratio | 1.600.0 | 1.60+0.1 | 1.47 | N/A |
| Debt-to-Equity | 0.150.0 | 0.15-0.0 | 0.17 | N/A |
| FCF Margin | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is JBS N.V.'s annual revenue?
JBS N.V. (JBS) reported $86.2B in total revenue for fiscal year 2025. This represents a 11.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is JBS N.V.'s revenue growing?
JBS N.V. (JBS) revenue grew by 11.7% year-over-year, from $77.2B to $86.2B in fiscal year 2025.
Is JBS N.V. profitable?
Yes, JBS N.V. (JBS) reported a net income of $2.2B in fiscal year 2025, with a net profit margin of 2.6%.
How much debt does JBS N.V. have?
As of fiscal year 2025, JBS N.V. (JBS) had $4.6B in cash and equivalents against $1.4B in long-term debt.
What is JBS N.V.'s net profit margin?
JBS N.V. (JBS) had a net profit margin of 2.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is JBS N.V.'s return on equity (ROE)?
JBS N.V. (JBS) has a return on equity of 23.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is JBS N.V.'s free cash flow?
JBS N.V. (JBS) generated $832.7M in free cash flow during fiscal year 2025. This represents a -69.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is JBS N.V.'s operating cash flow?
JBS N.V. (JBS) generated $2.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are JBS N.V.'s total assets?
JBS N.V. (JBS) had $45.2B in total assets as of fiscal year 2025, including both current and long-term assets.
What are JBS N.V.'s capital expenditures?
JBS N.V. (JBS) invested $2.1B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is JBS N.V.'s current ratio?
JBS N.V. (JBS) had a current ratio of 1.60 as of fiscal year 2025, which is generally considered healthy.
What is JBS N.V.'s debt-to-equity ratio?
JBS N.V. (JBS) had a debt-to-equity ratio of 0.15 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is JBS N.V.'s return on assets (ROA)?
JBS N.V. (JBS) had a return on assets of 4.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is JBS N.V.'s Piotroski F-Score?
JBS N.V. (JBS) has a Piotroski F-Score of 7 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are JBS N.V.'s earnings high quality?
JBS N.V. (JBS) has an earnings quality ratio of 1.31x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is JBS N.V.?
JBS N.V. (JBS) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.